InvestorsHub Logo
Followers 29
Posts 5387
Boards Moderated 0
Alias Born 11/21/2019

Re: jonselow post# 2860

Wednesday, 03/16/2022 10:19:31 AM

Wednesday, March 16, 2022 10:19:31 AM

Post# of 3504
Sky is the limit! Solid research, solid management, great future with this company and multiple biotech products on the line!

This is a pilot study of $STAB’s drug STAT-205 treatment of long haul COVID-19 is a REAL DEAL!. Michael K. Handley, CEO, says the company has a vibrant ‘clinical stage pipeline’ and it has recently submitted to the FDA a Phase 3 clinical trial protocol for its STAT-201 candidate for the treatment of pediatric Crohn’s Disease. $STAB